Deel

The Numbers at a Glance

Deel is private and does not file with the SEC. Valuation and round data are company-confirmed; ARR and profitability are company-disclosed or press-reported and are not audited public financials. Public comparables are computed by QuantLogix from current market capitalisation against trailing-twelve-month revenue in SEC filings, as of August 15, 2026.

1 · Business Overview

Selling legal presence, not software

Founded in 2019 by Alex Bouaziz and Shuo Wang and headquartered in San Francisco, Deel began as a way to pay international contractors and became the infrastructure layer for cross-border employment. A company in New York that wants to hire an engineer in Portugal has two options: spend six figures and several months incorporating a Portuguese entity and learning Portuguese labour law, or rent Deel's. Deel employs that engineer through its own local entity — the employer-of-record (EOR) model — and bills the customer a flat monthly fee per worker.

That is a deceptively deep business. The product surface is software, but the asset is a network of owned legal entities in roughly 100 countries, each carrying local payroll registration, tax filing obligations, benefits arrangements and statutory compliance. Deel now serves customers hiring across 150+ countries. Competitors that rent third-party entities instead of owning them move faster into new markets but inherit less control over compliance and margin — a distinction that matters enormously when a labour regulator comes asking who, exactly, the employer is.

• Deel EOR — full employment through Deel's local entity. The flagship, and the highest-priced seat.
• Deel Contractor — compliant contractor payments and classification, the original wedge product.
• Deel Global Payroll — running payroll for customers who own their own entities.
• Deel HR / Deel IT — HRIS and device management, the land-and-expand layer that raises revenue per customer.

Published pricing as of April 2026 puts EOR seats around $599/month list (about $499 on annual terms, and materially lower at scale) and contractor management near $49/month. The mix matters: EOR is the revenue engine, contractor is the funnel.

2 · The Moat — and Its Honest Limits

Regulatory surface area is the barrier to entry

The defensibility argument for Deel is not network effects and it is not brand. It is accumulated regulatory surface area. Every owned entity is a small, permanent operational cost and a large one-time setup cost; a competitor wanting parity has to repeat that in a hundred jurisdictions while Deel keeps compounding. Switching costs compound on the customer side too — moving employer of record for a distributed workforce means re-papering employment contracts for real people in many countries at once, which finance teams avoid unless something has gone badly wrong.

Two limits deserve stating plainly. First, this is not a winner-take-all market: Rippling, Remote, Papaya Global, Multiplier, Oyster and Velocity Global all sell credible EOR, and incumbents ADP and Workday own the payroll relationship at the enterprise tier. Second, EOR carries regulatory tail risk that software does not. Permanent-establishment rules, worker-classification enforcement and local labour courts can reprice the model in a given country with little warning. That risk is diversified across geographies, which helps, but it does not disappear.

3 · Financials & the Gross-vs-Net Trap

The single most important number to get right

Deel's disclosed trajectory is genuinely strong: roughly $800M ARR in early 2025, a $1B run rate announced in June 2025, and past $1.5B by August 2026 — close to a doubling in eighteen months at a scale where most companies decelerate. Management says the business reached profitability in late 2025, which if it holds through an audit is the rarest thing in this cohort.

But there is a trap waiting in the S-1, and any serious pre-IPO investor should anticipate it. In the EOR model, enormous sums flow through Deel that are not Deel's revenue — the salaries, employer taxes and benefits of every worker it employs on a customer's behalf. Whether those flows are reported gross or net is an accounting judgement with a dramatic effect on the optics of the top line. The public market already prices this distinction: TriNet, a PEO that reports substantial pass-through amounts in revenue, trades near 0.6x trailing revenue, while pure-software HCM names trade at 4–7x. Deel's $1.5B is described as recurring platform revenue, not payroll volume — the S-1 will have to prove that, and the multiple the market grants depends almost entirely on the answer.

4 · IPO Status & Timeline

Every preparation signal except the filing itself

As of publication, no Deel S-1 has appeared publicly and no date has been announced. What exists is a consistent pattern of preparation. In November 2025 Deel appointed Joe Kauffman, previously an Intuit finance executive, as CFO — a hire the company framed around leading it to a public listing. The $300M Series E at $17.3B closed the following month with Ribbit Capital leading, a round that reads more like a pre-IPO balance-sheet strengthening than a company that needs capital to operate. Deel has also earmarked roughly $500M for acquisitions and is spending it: in August 2026 it acquired the Israeli deepfake-detection startup Clarity in a deal reported around $40–50M, folding identity-fraud defence into onboarding — a sensible buy when your product is vouching for who someone is in a country you have never met them in.

Management has publicly tied timing to two conditions: market conditions and resolution of the Rippling litigation. The second is the binding constraint, and it is the subject of the next section.

5 · The Rippling Litigation — the Gating Item

Allegations, not findings — but disclosable either way

In 2025 Rippling sued Deel, alleging that Deel cultivated an employee inside Rippling to pass along trade secrets and sales intelligence. The case has not gone away quietly. A San Francisco federal judge, Charles Breyer, permitted racketeering and trade-secret claims to proceed rather than dismissing them, meaning the allegations were found sufficiently pleaded to be tested. Parallel proceedings ran in Ireland, where in March 2026 the High Court addressed the status of individual Deel executives as named defendants. Court filings unsealed during the dispute concern payments connected to the alleged source.

Deel denies wrongdoing, has contested the claims on multiple procedural fronts including forum, and has countersued — alleging that Rippling ran an infiltration effort of its own and characterising the suit as a competitive smear. Nothing here has been established as fact against either company, and this brief takes no position on the merits.

What matters for an IPO investor is narrower and does not require picking a side. Unresolved litigation of this character becomes a risk factor in an S-1, subjects executives to discovery and deposition during the exact months a roadshow demands their attention, and introduces a tail of unquantified liability into a prospectus. That is why timing is tied to it. A settlement removes the single largest obstacle between Deel and a listing; an adverse ruling would raise questions that go beyond money to governance — which is the more expensive kind of question for a company asking public shareholders for trust.

6 · Competitive Landscape

A two-horse race with incumbents circling

The obvious rivalry is with Rippling, which has also crossed $1B ARR and is growing quickly, and which approaches the market from the opposite direction — a US-first HR, IT and finance suite extending outward — while Deel came from global-first and is extending inward into HR and IT. The two are converging on the same product surface from different starting points, which is exactly why the relationship became litigious.

The under-appreciated competitive fact is that ADP and Workday already own the enterprise payroll relationship. They have been slower in cross-border EOR, but they hold the incumbency, the compliance brand and the CFO relationship. The bull case requires believing Deel's head start in owned entities is durable enough that incumbents choose to partner or acquire rather than build.

7 · Valuation Framework

What has to be true to justify 11.5x

At $17.3B against $1.5B of ARR, Deel carries roughly an 11.5x revenue multiple. Every public comparable sits well below that on trailing revenue, computed here from live market capitalisation against TTM revenue in SEC filings:

The spread between TriNet at 0.6x and Paychex at 6.7x is not a market inefficiency — it is the market pricing revenue quality. That is the whole valuation question for Deel in one row. If Deel's $1.5B is genuinely recurring platform revenue at software-like gross margin, then a premium to Paychex is arguable on growth alone, and 11.5x becomes a question of degree. If a material share proves to be lower-margin services or pass-through, the comparable set shifts toward the bottom of that table and the current mark looks stretched.

A simple frame for the listing: at 8x a $1.8–2.0B forward ARR, Deel prices around $14–16B — below the last private round. At 11–12x, it prices at or slightly above $17.3B, validating the Series E. Above 15x requires the market to accept it as a high-growth software compounder rather than a global-employment operator. Late-stage investors from the October 2025 round are, in effect, underwriting the middle case.

8 · Key Risks

9 · Pre-IPO Exposure Routes Today

There is no clean public proxy for Deel. The honest options, with their honest drawbacks:

• Secondary marketplaces — platforms such as Nasdaq Private Market list Deel interests. Accredited-investor gated, priced at a spread to the last primary mark, subject to company transfer approval, and illiquid until a listing.
• Late-stage venture funds — diversified access to the cohort, but you buy the whole portfolio and the fee load, not Deel.
• The public comp basket — ADP, PAYX, WDAY, PAYC, PCTY track the category's multiple regime. They will not capture Deel's growth, but they are the cleanest read on what the market is willing to pay for payroll revenue when Deel prices.
• Wait for the roadshow — for most investors this is the rational answer. The S-1 resolves the revenue-quality question that determines whether $17.3B was cheap or rich, and it does so before you have to commit capital.